Organon (OGN) Non-Current Debt (2021 - 2026)

Organon (OGN) posted quarterly Non-Current Debt of $8.6 billion for Q1 2026, down 4.29% year-over-year from $8.9 billion in Q1 2025, and down 0.87% on a QoQ basis from $8.6 billion in Q4 2025.

Organon (OGN) Non-Current Debt (2021 - 2026) Analysis & Trends

Organon (OGN) has reported Non-Current Debt for 6 consecutive years, with $8.6 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non-Current Debt fell 4.29% year-over-year to $8.6 billion; the TTM figure through Mar 2026 stood at $8.6 billion (down 4.29% YoY), while the FY2025 annual figure was $8.6 billion, down 2.62% from the prior year.
  • Non-Current Debt came in at $8.6 billion for Q1 2026 at Organon, down from $8.6 billion in the prior quarter.
  • The five-year high for Non-Current Debt was $9.1 billion in Q1 2022, with the low at $8.6 billion in Q1 2026.
  • Average Non-Current Debt over 5 years is $8.8 billion, with a median of $8.7 billion recorded in 2024.
  • Across the five-year window, Non-Current Debt declined 6.13% in 2022 and advanced 2.65% in 2025, its largest moves.
  • Year by year, Non-Current Debt stood at $8.9 billion in 2022, then fell by 1.73% to $8.8 billion in 2023, then grew by 1.25% to $8.9 billion in 2024, then slipped by 2.62% to $8.6 billion in 2025, then retreated by 0.87% to $8.6 billion in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $8.6 billion, $8.6 billion, and $8.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 39.37 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 37.53 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 64.53 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -24.45 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 46.67 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 51.89 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 20.86 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 60.57 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 8.55 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.55 Bn
Dec 31, 2025 8.63 Bn
Sep 30, 2025 8.78 Bn
Jun 30, 2025 8.78 Bn
Mar 31, 2025 8.94 Bn
Dec 31, 2024 8.86 Bn
Sep 30, 2024 8.74 Bn
Jun 30, 2024 8.65 Bn
Mar 31, 2024 8.71 Bn
Dec 31, 2023 8.75 Bn
Sep 30, 2023 8.65 Bn
Jun 30, 2023 8.72 Bn
Mar 31, 2023 8.70 Bn
Dec 31, 2022 8.91 Bn
Sep 30, 2022 8.69 Bn
Jun 30, 2022 8.88 Bn
Mar 31, 2022 9.09 Bn
Dec 31, 2021 9.13 Bn
Sep 30, 2021 9.26 Bn
Jun 30, 2021 9.31 Bn